Cargando…
Proarrhythmic risk assessment of drugs by dV (m) /dt shapes using the convolutional neural network
Comprehensive in vitro Proarrhythmia Assay (CiPA) projects for assessing proarrhythmic drugs suggested a logistic regression model using qNet as the Torsades de Pointes (TdP) risk assessment biomarker, obtained from in silico simulation. However, using a single in silico feature, such as qNet, canno...
Autores principales: | Jeong, Da Un, Yoo, Yedam, Marcellinus, Aroli, Kim, Ki‐Suk, Lim, Ki Moo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124356/ https://www.ncbi.nlm.nih.gov/pubmed/35579100 http://dx.doi.org/10.1002/psp4.12803 |
Ejemplares similares
-
Application of Convolutional Neural Networks Using Action Potential Shape for In-Silico Proarrhythmic Risk Assessment
por: Jeong, Da Un, et al.
Publicado: (2023) -
Assessment of Drug Proarrhythmicity Using Artificial Neural Networks With in silico Deterministic Model Outputs
por: Yoo, Yedam, et al.
Publicado: (2021) -
qInward variability-based in-silico proarrhythmic risk assessment of drugs using deep learning model
por: Jeong, Da Un, et al.
Publicado: (2022) -
Verification of the Efficacy of Mexiletine Treatment for the A1656D Mutation on Downgrading Reentrant Tachycardia Using a 3D Cardiac Electrophysiological Model
por: Qauli, Ali Ikhsanul, et al.
Publicado: (2022) -
Sensitivity Analysis of Cardiac Alternans and Tachyarrhythmia to Ion Channel Conductance Using Population Modeling
por: Jeong, Da Un, et al.
Publicado: (2022)